The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A unique gene expression signature in tumor positive or negative sentinel lymph nodes in patients with melanoma.
Ahmad A. Tarhini
Consultant or Advisory Role - Bristol-Myers Squibb; Merck; Roche/Genentech
Research Funding - Bristol-Myers Squibb; Merck; Novartis
Yan Lin
No relevant relationships to disclose
Hui-Min Lin
No relevant relationships to disclose
William A LaFramboise
No relevant relationships to disclose
Uma N. M. Rao
No relevant relationships to disclose
Hussein Abdul-Hassan Tawbi
Research Funding - GlaxoSmithKline; Merck
Madeeha Ashraf
No relevant relationships to disclose
James F. Pingpank
No relevant relationships to disclose
Matthew Peter Holtzman
No relevant relationships to disclose
Christin Sciulli
No relevant relationships to disclose
Cindy Sander
No relevant relationships to disclose
John M. Kirkwood
Consultant or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; Prometheus